SESANA, MARIA SILVIA
SESANA, MARIA SILVIA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Biodegradable SPI-based hydrogel for controlled release of nanomedicines: a potential approach against brain tumors recurrence
2024 Viale, F; Ciprandi, M; Leoni, L; Sierri, G; Renda, A; Barbugian, F; Koch, M; Sesana, S; Salvioni, L; Colombo, M; Mantegazza, F; Russo, L; Re, F
Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine
2024 Sierri, G; Patrucco, M; Ferrario, D; Renda, A; Comi, S; Ciprandi, M; Fontanini, V; Sica, F; Sesana, S; Costa Verdugo, M; Kravicz, M; Salassa, L; Busnelli, M; Re, F
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity
2023 Re, F; Giorgetti, S; Biondi, B; Scapin, S; Mantegazza, F; Cassina, V; Sesana, S; Rizzi, L; Eberini, I; Palazzolo, L; Beeg, M; Gobbi, M; Sardina, M; Masserini, M
Direct and indirect air pollution effects on synaptic neurotransmission linked to the development of neurodegenerative disease
2023 Di Girolamo, S; Terribile, G; Spaiardi, P; Biella, G; Sesana, S; Re, F; Sancini, G
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation
2023 Saresella, M; Zoia, C; La Rosa, F; Bazzini, C; Sala, G; Grassenis, E; Marventano, I; Hernis, A; Piancone, F; Conti, E; Sesana, S; Re, F; Seneci, P; Ferrarese, C; Clerici, M
Raman Spectroscopy Characterization of Multi-Functionalized Liposomes as Drug-Delivery Systems for Neurological Disorders
2023 Rodà, F; Picciolini, S; Mangolini, V; Gualerzi, A; Seneci, P; Renda, A; Sesana, S; Re, F; Bedoni, M
SPRi analysis of molecular interactions of mApoE-functionalized liposomes as drug delivery systems for brain diseases
2023 Picciolini, S; Rodà, F; Gualerzi, A; Mangolini, V; Forleo, L; Mangolini, A; Sesana, S; Antoniou, A; Re, F; Seneci, P; Bedoni, M
Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions
2022 Giofre, S; Renda, A; Sesana, S; Formicola, B; Vergani, B; Leone, B; Denti, V; Paglia, G; Groppuso, S; Romeo, V; Muzio, L; Balboni, A; Menegon, A; Antoniou, A; Amenta, A; Passarella, D; Seneci, P; Pellegrino, S; Re, F
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics
2022 Taiarol, L; Bigogno, C; Sesana, S; Kravicz, M; Viale, F; Pozzi, E; Monza, L; Carozzi, V; Meregalli, C; Valtorta, S; Moresco, R; Koch, M; Barbugian, F; Russo, L; Dondio, G; Steinkühler, C; Re, F
TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells
2022 Delfanti, G; Cortesi, F; Perini, A; Antonini, G; Azzimonti, L; de Lalla, C; Garavaglia, C; Squadrito, M; Fedeli, M; Consonni, M; Sesana, S; Re, F; Shen, H; Dellabona, P; Casorati, G
An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy
2020 Taiarol, L; Formicola, B; Magro, R; Sesana, S; Re, F
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide
2017 Gregori, M; Taylor, M; Salvati, E; Re, F; Mancini, S; Balducci, C; Forloni, G; Zambelli, V; Sesana, M; Michael, M; Michail, C; Tinker Mill, C; Kolosov, O; Scherer, M; Harris, S; Fullwood, N; Masserini, M; Allsop, D
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes
2016 Gregori, M; Orlando, A; Re, F; Sesana, M; Nardo, L; Salerno, D; Mantegazza, F; Salvati, E; Zito, A; Malavasi, F; Masserini, M; Cazzaniga, E
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS
2016 Zoia, C; Conti, E; Cereda, D; RODRIGUEZ MENENDEZ, V; Andreoni, S; Gregori, M; Sesana, M; Masserini, M; Tremolizzo, L; Ferrarese, C
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro
2015 Gregori, M; Bertani, D; Cazzaniga, E; Orlando, A; Mauri, M; Bianchi, A; Re, F; Sesana, M; Minniti, S; Francolini, M; Cagnotto, A; Salmona, M; Nardo, L; Salerno, D; Mantegazza, F; Masserini, M; Simonutti, R
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease
2015 Zoia, C; Conti, E; Ulisse, A; RODRIGUEZ MENENDEZ, V; Gregori, M; Sesana, M; Masserini, M; Ferrarese, C
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease
2014 Bana, L; Minniti, S; Salvati, E; Sesana, M; Zambelli, V; Cagnotto, A; Orlando, A; Cazzaniga, E; Zwart, R; Scheper, W; Masserini, M; Re, F
Role of lipid rafts and GM1 in the segregation and processing of Prion Protein
2014 Botto, L; Cunati, D; Coco, S; Sesana, M; Bulbarelli, A; Biasini, E; Colombo, L; Negro, A; Chiesa, R; Masserini, M; Palestini, P
Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages
2013 Orlando, A; Re, F; Sesana, M; Rivolta, I; Panariti, A; Brambilla, D; Nicolas, J; Couvreur, P; Andrieux, K; Masserini, M; Cazzaniga, E
Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model
2013 Re, F; Salvati, E; Sesana, M; Cambianica, I; Sancini, G; Masserini, M; Gregori, M